Other headlinesSectra lands multi-site contractMR/XR suites clear FDA
ProSolv alliance boosts outcomes reporting
Fujifilm’s ProSolv CardioVascular now provides the means to collect cardiology data for outcomes reporting, thanks to a partnership with Cedaron Medical. Integration of the cardiovascular PACS Synapse ProSolv with Cedaron’s CardiacCare solution provides a single point of access for all image management, clinical reporting, and outcomes reporting for diagnostic and interventional cardiac procedures, according to ProSolv. The unified system collects procedural information and automatically populates registry templates, such as the American College of Cardiology (ACC) National Cardiovascular Data, CathPCI, ICD, CARE and ACTION registries.
Sectra lands multi-site contract
Swedish PACS/IT vendor Sectra will supply and operate RIS/PACS for a dozen Norwegian radiology clinics under a six-year agreement signed with Curato, the owner of the clinics. The deal, valued at SEK 100 million ($14.6 million), also calls for the two companies to conduct joint research projects focused on imaging improving diagnostics.
MR/XR suites clear FDA
The FDA has cleared Manitoba-based IMRIS to market a combination MR and x-ray angiography suite that allows multi-modality imaging of neurovascular and cardiac patients before, during, and after interventions. IMRISNV and IMRIScardio are the first such suites in the world, according to the Canadian company. IMRISNV includes an integrated wide bore 3T MRI scanner and bi-plane angiography system. IMRIScardio comes equipped with a wide-bore 1.5T MRI scanner and a single-plane or bi-plane angiography system. IMRIS received CE Mark regulatory approval in Europe for IMRISNV and IMRIScardio earlier this year. A marketing application is pending with Health Canada.